145 related articles for article (PubMed ID: 14163645)
1. [CLINICAL STUDIES ON THE INTERMEDIARY METABOLISM OF TYROSINE. 1. URINARY EXCRETION OF INTERMEDIARY METABOLITES OF TYROSINE IN HEALTHY INDIVIDUALS AND PATIENTS WITH LIVER DISORDERS].
AKISAWA J
Naika Hokan; 1964 Mar; 11():85-95. PubMed ID: 14163645
[No Abstract] [Full Text] [Related]
2. [CLINICAL STUDIES ON INTERMEDIARY METABOLISM OF TYROSINE. 2. URINARY EXCRETION OF INTERMEDIARY METABOLITES OF TYROSINE IN PATIENTS WITH BLOOD DISORDERS].
AKISAWA J
Naika Hokan; 1964 Mar; 11():97-109. PubMed ID: 14163646
[No Abstract] [Full Text] [Related]
3. [CLINICAL STUDIES ON THE INTERMEDIARY METABOLISM OF TYROSINE. 3. URINARY EXCRETION ON INTERMEDIARY METABOLITES OF TYROSINE IN PATIENTS WITH SOME ENDOCRINE DISEASES AND THE RELATED DISORDERS].
AKISAWA J
Naika Hokan; 1964 Apr; 11():163-72. PubMed ID: 14171676
[No Abstract] [Full Text] [Related]
4. STUDIES ON TYROSINOSIS: 1, EFFECT OF LOW-TYROSINE AND LOW-PHENYLALANINE DIET.
HALVORSEN S; GJESSING LR
Br Med J; 1964 Nov; 2(5418):1171-3. PubMed ID: 14190487
[No Abstract] [Full Text] [Related]
5. [EXCRETION OF HIPPURIC ACID AND BENZOYLGLUCURONIC ACID FOLLOWING SODIUM BENZOATE LOAD IN NORMAL SUBJECTS AND IN LIVER DISEASES].
LYCZEWSKA J; RAFALOWICZ A
Med Dosw Mikrobiol; 1963; 15():349-58. PubMed ID: 14118924
[No Abstract] [Full Text] [Related]
6. [THE SIGNIFICANCE OF THE RELATION BETWEEN THE QUANTITY AND SPECIFIC WEIGHT OF URINE EXCRETED AFTER THE WOLLHEIM WATER TOLERANCE TEST IN LIVER DISEASES].
DELUTTEROTTI A; MAINIERI L; CIPOLLI PL
Gazz Int Med Chir; 1963 Oct; 67():1972-81. PubMed ID: 14095272
[No Abstract] [Full Text] [Related]
7. [CLINICAL, BIOCHEMICAL AND ANATOMOPATHOLOGICAL STUDY OF CHRONIC HEPATITIS AND POSTHEPATITIS CIRRHOSIS].
DEGROOTE J
Verh K Vlaam Acad Geneeskd Belg; 1964; 26():85-171. PubMed ID: 14158180
[No Abstract] [Full Text] [Related]
8. [ON TRANSAMINASES PARTICIPATING IN THE CONVERSION OF TYROSINE TO P-HYDROXYPHENYLPYRUVATE].
LUDWIG H; EWALD W; ROKA L
Hoppe Seylers Z Physiol Chem; 1964; 337():114-22. PubMed ID: 14238845
[No Abstract] [Full Text] [Related]
9. Tyrosine metabolism in cirrhosis: acquired alkaptonuria.
Nordlinger BM; Fulenwider JT; Faraj BA; Bethel RA; Rudman D
Surg Forum; 1978; 29():442-4. PubMed ID: 401217
[No Abstract] [Full Text] [Related]
10. [CLINICAL INVESTIGATIONS OF PYRUVIC ACID METABOLISM IN LIVER DISEASES. I. PYRUVIC ACID LEVEL OF THE BLOOD IN LIVER DISEASES AND ITS DYNAMICS].
KONO H
Acta Med Okayama (1952); 1964 Feb; 18():15-31. PubMed ID: 14201059
[No Abstract] [Full Text] [Related]
11. DIPHENYLHYDANTOIN AND PHENOBARBITAL TOXICITY. THE ROLE OF LIVER DISEASE.
KUTT H; WINTERS W; SCHERMAN R; MCDOWELL F
Arch Neurol; 1964 Dec; 11():649-56. PubMed ID: 14202182
[No Abstract] [Full Text] [Related]
12. [LIVER DISEASES].
UEDA H; HARADA T
Naika; 1964 Jan; 13():11-7. PubMed ID: 14110420
[No Abstract] [Full Text] [Related]
13. [PHENOLSTEROID AND 17-KETOSTEROID EXCRETION IN VIRAL HEPATITIS].
ZOLLIKOFER H; MATTER M; TOBLER R
Acta Hepatosplenol; 1963; 10():341-60. PubMed ID: 14099396
[No Abstract] [Full Text] [Related]
14. THE METABOLISM OF ORTHO-I-131 IODOBENZOIC ACID. I. ITS USE AS A POSSIBLE LIVER FUNCTION TEST.
TUBIS M; BLAHD WH; ENDOW JS; RAWALAY SS
J Nucl Med; 1964 Jul; 5():532-41. PubMed ID: 14216631
[No Abstract] [Full Text] [Related]
15. [EFFECT OF SHORT-WAVES ON SOME FUNCTIONS OF THE LIVER].
LINDEMANN A; TEICHMANN W
Z Gesamte Inn Med; 1964 Sep; 19():705-11. PubMed ID: 14232730
[No Abstract] [Full Text] [Related]
16. Tyrosine metabolism in cirrhosis.
Nordlinger BM; Fulenwider JT; Ivey GL; Faraj BA; Ali FM; Kutner M; Henderson JM; Rudman D
J Lab Clin Med; 1979 Dec; 94(6):832-40. PubMed ID: 501206
[TBL] [Abstract][Full Text] [Related]
17. CLINICAL SIGNIFICANCE OF ALDOSTERONE IN LIVER DISEASES.
GERASIMOVA EN; LOGINOV AS
Fed Proc Transl Suppl; 1964; 23():194-6. PubMed ID: 14111995
[No Abstract] [Full Text] [Related]
18. [ON THE DETERMINATION OF URINARY UROBILINOGEN. UROBILINOGEN CONTENT IN THE URINE OF PATIENTS WITH LIVER DISEASES AND ACUTE COMMUNICABLE DISEASES].
CHIN B
Rinsho Byori; 1964 Jan; 12():62-6. PubMed ID: 14150045
[No Abstract] [Full Text] [Related]
19. STUDIES OF SULFOBROMOPHTHALEIN SODIUM (BSP) METABOLISM IN MAN. I. IN NORMAL SUBJECTS AND PATIENTS WITH HEPATIC DISEASE.
SCHOENFIELD LJ; FOULK WT; BUTT HR
J Clin Invest; 1964 Jul; 43(7):1409-18. PubMed ID: 14192521
[No Abstract] [Full Text] [Related]
20. [Frequency and prognostic significance of disorders and liver dysfunction after hepatitis].
KUHN HA; HITZELBERGER A
Dtsch Med Wochenschr; 1952 Dec; 77(50):1562-5. PubMed ID: 13043350
[No Abstract] [Full Text] [Related]
[Next] [New Search]
